More Deaths Reported After J&J, AstraZeneca Vaccines, Plus Researchers Link AstraZeneca to Strokes in Young Adults

More Deaths Reported After J&J, AstraZeneca Vaccines, Plus Researchers Link AstraZeneca to Strokes in Young Adults

The AstraZeneca and Johnson & Johnson COVID vaccines came under scrutiny again this week as more reports of deaths — largely due to blood clot disorders — surfaced in Belgium, Canada and Greece, and a new report linked the AstraZeneca vaccine to strokes in young adults.

By Megan Redshaw

The Defender is experiencing censorship on many social channels. Be sure to stay in touch with the news that matters by subscribing to our top news of the dayIt’s free.

The AstraZeneca and Johnson & Johnson (J&J) COVID vaccines came under scrutiny again this week as more reports of deaths — largely due to blood clot disorders — surfaced in Belgium, Canada and Greece.

Adding to the vaccine makers’ woes is a new report out of London from researchers who identified the first cases of strokes occurring in young adults who received the AstraZeneca vaccine, which was co-developed by the University of Oxford University in the UK.

Belgium suspends use of J&J vaccine

Belgium said Wednesday it was suspending vaccinations with J&J vaccine, for people under the age of 41, following the death of a woman from blood clots after she received the shot. This is the second time Belgium has paused the one-shot vaccine.

“The Inter-ministerial conference has decided to temporarily administer Janssen’s vaccine to the general population from the age of 41 years, pending a more detailed benefit-risk analysis by the EMA,” said a statement issued by Belgium’s federal health minister and seven regional counterparts.

The woman, who was under the age of 40, died May 21 after being admitted to the hospital with severe thrombosis and platelet deficiency, Reuters reported.

The government asked for urgent advice from the European Union’s drug regulator, the European Medicines Agency (EMA), before it would consider lifting the suspension.

The EMA said it is reviewing the death of the woman in Belgium, along with other reports of blood clots, with the Belgian and Slovenian medicines agencies, and has asked J&J to carry out a series of additional studies to help assess a possible link between the shot and rare blood clots.

J&J said April 20 it would resume the roll-out in the EU of its COVID vaccine, marketed under the company’s Janssen subsidiary — with a warning on its label — after several countries, including Belgium, first paused the vaccine amid concerns of its possible link to blood clotting disorders.

The EMA confirmed a “possible link,” but concluded the vaccine’s benefits outweighed the risks. The drug regulator’s safety committee (PRAC) said a warning should be added to the product label, but the blood clot-related disorders should be listed as “very rare” side effects of the vaccine.

On April 23, the Centers for Disease Control and Prevention (CDC) voted to resume the use of J&J’s vaccine without restrictions after the vaccine was paused to investigate reports of rare blood clots. The recommendation by the CDC’s advisory panel said the link between blood clots and J&J’s COVID vaccine was “plausible,” but concluded the vaccine’s benefits outweighed the risks and recommended use for persons 18 years of age and older in the U.S. under the FDA’s Emergency Use Authorization.

J&J has said no clear causal relationship has been established between its vaccine and blood clots.

Researchers identify strokes in young adults after AstraZeneca shot

The first cases of large-vessel arterial occlusion strokes in young adults linked to AstraZeneca’s vaccine were described in detail for the first time in a letter published online in the Journal of Neurology Neurosurgery & Psychiatry.

The three cases, one of which was fatal, occurred in two women and one man in their 30s or 40s who developed characteristics of vaccine-induced immune thrombotic thrombocytopenia (VITT), a reaction associated with the AstraZeneca vaccine.

“These are the first detailed reports of arterial stroke believed to be caused by VITT after the AstraZeneca COVID vaccine, although stroke has been mentioned previously in the VITT data,” senior author, Dr. David Werring, professor of clinical neurology at the Stroke Research Centre, University College London Queen Square Institute of Neurology, told Medscape Medical News.

“VITT has more commonly presented as CVST (cerebral venous sinus thrombosis) which is stroke caused by a venous thrombosis; these cases are showing that it can also cause stroke caused by an arterial thrombosis,” Werring explained.

Werring noted the reports do not add anything to the overall risk/benefit of the vaccine, as they are describing only three cases. “While VITT is very serious, the benefit of the vaccine still outweighs its risks,” he said.

The first case, a 35-year-old woman, experienced intermittent headaches on the right side and around her eyes for six days after vaccination. Five days later, she awoke feeling drowsy and with weakness to her left face, arm and leg.

Imaging revealed the woman had a blocked right middle cerebral artery with brain infarction and clots in the right portal vein. She underwent brain surgery to reduce the pressure in her skull, plasma removal and replacement, and treatment with anticoagulant and fondaparinux, but suffered brain stem death and subsequently died.

The second case, a 37-year-old woman, presented with headache, confusion, weakness in her left arm and loss of vision on the left side 12 days after vaccination with AstraZeneca. Imaging showed occlusion of both carotid arteries, as well as blood clots in her lungs and brain. She improved clinically with treatment.

The third case occurred in a 43-year-old man who presented 21 days after vaccination with problems speaking. Imaging showed a clot in the left middle cerebral artery. He was treated and remains stable.

The researchers said young patients presenting with ischaemic stroke after receiving AstraZeneca’s vaccine should urgently be evaluated for VITT.

Ontario man dies from ‘rare but real’ blood clot after first dose of AstraZeneca

An Ontario man in his 40s died after receiving his first dose of the AstraZeneca vaccine, public health officials confirmed Tuesday.

Dr. Barbara Yaffe, Ontario’s associate chief medical officer of health, said his death is being investigated, but the man suffered from VITT.

“While the investigation is ongoing and a final cause of death has yet to be officially determined, it has been confirmed that the individual did have VITT at the time of his death,” Yaffe said Tuesday. “The risks associated with this vaccine are [rare], but they are real.”

Chief Medical Officer Dr. David Williams restricted AstraZeneca vaccinations for people who have not yet received the first dose as of May 11, due to a higher-than-expected rate of blood clots.

Greece investigating four cases of blood clots after AstraZeneca shot

Α 63-year-old woman from Greece died of blood clots after vaccination with AstraZeneca. The case was one of four being investigated by the National Organization for Medicines (EOF) for a potential correlation between AstraZeneca’s vaccine and rare blood clots, according to the Greek City Times.

Also in Greece, a 44-year-old woman is in serious condition after experiencing VITT. Her case was the second incident found by EOF to be linked to the vaccine, according to the Greek Reporter.

A third blood clotting incident involved a 35-year-old man from Crete who suffered two blood clots after receiving AstraZeneca’s vaccine. The man was hospitalized after suffering a clot in his leg a few days after getting the jab. He suffered a second blood clot in his brain while hospitalized

As The Defender reported April 7, European regulators said they confirmed a “possible link” between AstraZeneca’s COVID vaccine and “very rare” blood clots, but concluded the benefits of the vaccine still outweigh the risks.

The EMA did not recommend restricting use of the vaccine based on age, gender or other risk factors, but did say cases of blood clotting after vaccination “should be” listed as a possible side effect, according to a statement issued by the agency’s safety committee.

The AstraZeneca vaccine is not yet authorized for use in the U.S.

Nobel Prize winner: Mass COVID vaccination an ‘Unacceptable Mistake’ that is ‘Creating the Variants’

Nobel Prize Winner: Mass Vaccination an "Unacceptable Mistake"

In every country, ‘the curve of vaccination is followed by the curve of deaths,’ the famous virologist said

 

As published on LifeSite News by Celeste McGovern

French virologist and Nobel Prize winner Luc Montagnier called mass vaccination against the coronavirus during the pandemic “unthinkable” and a historical blunder that is “creating the variants” and leading to deaths from the disease.

“It’s an enormous mistake, isn’t it? A scientific error as well as a medical error. It is an unacceptable mistake,” Montagnier said in an interview translated and published by the RAIR Foundation USA yesterday. “The history books will show that, because it is the vaccination that is creating the variants.”

 

Many epidemiologists know it and are “silent” about the problem known as “antibody-dependent enhancement,” Montagnier said.

“It is the antibodies produced by the virus that enable an infection to become stronger,” he said in an interview with Pierre Barnérias of Hold-Up Media earlier this month. 

Vaccination leading to variants

“It is clear that the new variants are created by antibody-mediated selection due to the vaccination.”

Vaccinating during a pandemic is “unthinkable” and is causing deaths, the winner of the 2008 Nobel Prize in Medicine for discovery

‘Deaths follow vaccination’

“The new variants are a production and result from the vaccination. You see it in each country, it’s the same: in every country deaths follow vaccination,” he said.

A video published last week on YouTube uses data from the Institute for Health Metrics and Evaluation at the University of Washington to illustrate the spikes in deaths in numerous countries across the globe after the introduction of COVID vaccination, confirming Montagnier’s observation.

The French interviewer pointed to data from the World Health Organization(WHO) showing that since the vaccines were introduced in January, new infections contamination have “exploded,” along with deaths, “notably among young people.”

Image
Image

“Yes,” agreed Montagnier who is a professor at Shanghai Jiao Tong University. “With thrombosis, etc.”

Thrombosis – or blood clots — have been an unexpected problem linked to the new coronavirus vaccines and the cause of AstraZeneca’s vaccine being pulled in several countries. The head of Canada’s public health agency, Theresa Tam, told a press conference Tuesday that there are now 21 confirmed cases of vaccine-induced thrombotic thrombocytopenia, or VITT, including among three women who died from the blood-clotting disorder potentially linked to AstraZeneca’s vaccine and another 13 cases are under investigation. 

Breakthrough cases

Montagnier said that he is currently conducting research with those who have become infected with the coronavirus after getting the vaccine. The Centers for Disease Control and Prevention reported in April that it had received 5,800 reports of people who had “breakthrough” COVID after being vaccinated, including 396 people who required hospitalization and 74 patients who died. 

“I will show you that they are creating the variants that are resistant to the vaccine,” Montagnier said.

Coronavirus made in a lab

The famous French virologist created waves in April 2020 when he told a French television station that he believed SARS-CoV2, the new pandemic coronavirus, was man-made in a laboratory. The “presence of elements of HIV and germ of malaria in the genome of coronavirus is highly suspect and the characteristics of the virus could not have arisen naturally,” he said

Though he was ridiculed by French experts for having “a conspiracy vision that does not relate to the real science,” Montagnier published a paper in July 2020 supporting his claims that the novel coronavirus must have originated from human experimentation in a lab – a theory that has recently resurfaced and is currently considered the most likely origin of the virus.

 

To view the original article, please click here

 

 

 

Government Caught “Scrubbing” Covid-19 Vaccine Injuries and Deaths

Government caught "scrubbing" Covid-19 vaccine injuries and deaths

Dr. Peter McCullough, one of the world’s premiere medical doctors who specializes in treating the Wuhan coronavirus (Covid-19), told journalist Alex Newman during a recent interview that the United States government is lying about the true number of Chinese Virus vaccine reactions that are occurring. The government’s strategy, McCullough says, which is coordinated with the Bill & Melinda Gates Foundation and the World Health Organization (WHO), has resulted in tens of thousands of unnecessary deaths that are being ignored or swept under the rug. This is unprecedented because the government has pulled past drugs and vaccines from the market for far less. Between Dec. 14 and April 23, Donald Trump’s “Operation Warp Speed” jabs caused at least 3,544 deaths along with 12,619 serious injuries. Neither the Food and Drug Administration (FDA) nor the Centers for Disease Control and Prevention (CDC), however, are at all concerned. “A typical new drug at about five deaths, unexplained deaths, we get a black-box warning, your listeners would see it on TV, saying it may cause death,” McCullough stated. “And then at about 50 deaths, it’s pulled off the market.” Back in 1976 during the “swine flu” crisis, the U.S. attempted to jab some 55 million Americans but stopped the program after 500 cases of paralysis and 25 deaths were reported. Compare that to the Wuhan Flu shots of today, which are still being aggressively pushed despite untold thousands of injuries and deaths. “In the U.S. today [as of late March] we have approximately 77 million people vaccinated for COVID and we have 2,602 deaths reported, so it’s unprecedented how many deaths have accrued,” McCullough further explained. “Then on March 8 the CDC announced on their website with very little fanfare that they had reviewed about 1,600 deaths with unnamed FDA doctors and they indicated not a single death was related to the vaccine. he added. I think that was concerning in the academic community.”

Wuhan Flu shots are mass genocide

Had the CDC truly conducted such an investigation, McCullough says, it would have taken months to complete. Instead, the CDC rolled it out in a matter of days to declare all of the jabs “safe and effective” so the program would continue. “I have chaired and participated in dozens of data safety monitoring boards and sat on those committees and I can tell you that this type of work would have taken many months to review all the labs, the death certificates and all the circumstances of an event,” McCullough explained. “It is impossible for unnamed regulatory doctors without any experience with COVID-19 to opine that none of the deaths were related to the vaccine.” Another factor to consider is that only about 1-10 percent of all vaccine-related deaths even get logged into the CDC’s Vaccine Adverse Event Reporting System (VAERS). This suggests that many thousands more deaths are not even included in the official numbers. Even without this missing data, Chinese Virus injections are already proving to be far more dangerous than seasonal flu shots. Every year, 20-30 deaths from flu shots are reported to VAERS based on 195 million injections. Wuhan Flu shots, on the other hand, have already caused at least 2,602 deaths based on 77 million injections. “So the U.S. government has made a decision, along with the stakeholders – the CDC, NIH, FDA, Big Pharma, World Health Organization, Gates Foundation – they have made a commitment to mass vaccination as the solution to the COVID pandemic and we are really going to be witness to what’s going to happen in history,” McCullough warns. “We’re sitting on, right now, the biggest number of vaccine deaths, there’s been tens of thousands of hospitalizations, all attributable to the vaccine, and going strong.” More related news can be found at Pandemic.news

Sources for this article include: LeoHohmann.com NaturalNews.com

19,916 ‘eye disorders’ including blindness following COVID vaccine reported in Europe

19,916 ‘eye disorders’ including blindness following COVID vaccine reported in Europe

More than 10,000 reports of eye disorders after COVID shots in the U.K. alone

By Celeste McGovern

May 1, 2021 (LifeSiteNews) – Hundreds of cases of blindness are among the 19,916 reports of “eye disorders” to the World Health Organization’s European drug monitoring agency following injection of experimental COVID-19 vaccines

The nearly 20,000 eye disorders reported to VigiBase, a database for the WHO maintained by the Uppsala Monitoring Centre(UMC) in Uppsalla, Sweden, include:

  • Eye pain (4616)
  • Blurred vision  (3839)
  • Photophobia or light intolerance (1808)
  • Visual impairment (1625)
  • Eye swelling (1162)
  • Ocular hyperaemia or red eyes (788)
  • Eye irritation (768)
  • Itchy eyes or eye pruritus (731)
  • Watery eyes or increased lacrimation (653)
  • Double vision or diplopia (559)
  • Eye strain or asthenopia (459)
  • Dry eye (400)
  • Swelling around the eye or periorbital swelling (366)
  • Swelling of eyelid (360)
  • Flashes of light in the field of vision or photopsia (358)
  • Blindness (303)
  • Eyelid oedema (298)
  • Eye or ocular discomfort (273)
  • Conjunctival haemorrhage or breakage of a small eye vessel (236)
  • Blepharospasm or abnormal contraction of an eye muscle(223)
  • Vitreous floaters (192)
  • Periorbital oedema (171)
  • Eye haemorrhage (169)

More than half of the eye disorders (10, 667) were also reported to the U.K.’s Yellow Card adverse event reporting system. These would have followed injection primarily of AstraZeneca’s and Pfizer’s COVID-19 vaccines but included eight reports of eye disorders among the 228 reports concerning Moderna’s vaccine, of which only 100,000 first doses had been administered by April 21.

Eye disorders were not reported in the clinical trials for vaccines which have been granted Emergency Use Authorization (EUA) only. The U.S. Food and Drug Administration’s fact sheet for those administering Pfizer’s experimental vaccine does not mention eye side effects. It does state, however, that “Additional adverse reactions, some of which may be serious, may become apparent with more widespread use of the Pfizer-BioNTech COVID-19 Vaccine.”

VAERS reports

VigiBase and Yellow Card reports do not offer details of the patients’ experiences of adverse side-effects. However, those in the U.S. Vaccine Adverse Event Reporting System (VAERS) system include some reporting on the patient, his or her age, and the general case presentation.

One VAERS report describes a 33-year-old pilot from Mississippi who took Pfizer’s vaccine and developed vision problems among numerous other symptoms.

“I noticed a headache in the very top of my head within an hour of getting the vaccine,” he reported. “I thought it was normal because everyone I know said they got a headache from it. Over the next few hours, the pain moved down the back of my neck and became a burning sensation at the bottom of my skull.”

“Two days after receiving the vaccine I flew my plane and immediately noticed something was wrong with me,” the report continues. “I was having a very hard time focusing. Approximately 2 hours into my flying I felt sudden and extreme pressure in my head and nearly blacked out. I immediately landed and stopped flying.”

The pilot experienced the same thing two days later when he tried flying again. The burning in his neck intensified and was accompanied by dizziness, nausea, disorientation, confusion, uncontrollable shaking, and tingling in his toes and fingers.

The patient was diagnosed with vertigo and prescribed a medication which provided “no relief,” according to the VAERS account. He underwent extensive testing including balance, eye, and hearing tests, CT and MRI scans, and he was informed that an allergic reaction to the Pfizer COVID vaccine had increased the pressure in his spinal cord and brain stem.

“That pressure causes my vision problems and ultimately ruptured my left inner ear breaking off several crystals in the process,” the report states.  “I cannot fly with this condition. I’m currently taking Diamox to reduce the pressure in my spinal cord and brain stem.”

More than 1,200 reports to VAERS include “eye pain” among the listed symptoms. One report filed by a 50-year-old physician from Wisconsin for himself said he experienced “severe sweating; fever; weakness” and the “worst headache of my life” following receiving a second dose of Pfizer’s Wuhan coronavirus vaccine in January.  The doctor said he experienced “searing eye pain for the last 2 months” and “daily headaches” – events described as a “disability” and “permanent damage.”

One 26-year-old student in California received Johnson & Johnson’s vaccine on April 9 and reported experiencing “typical” post-vaccine symptoms of nausea, muscle aches, chills, fatigue which “dissipated.” On the fifth day following the shot, however, she went for a light walk in the morning and “completely lost vision in both eyes.” She also described her “excruciating headache behind eyes” as the “worst headache of my life.” At a hospital emergency ward she was given morphine which she reported did not help the pain and a head CT scan ruled out a clotting event. Her report filed six days later, said: “I’m terrified because I know something is very wrong.”

‘Frightening, stressful, and uncertain’

Michelle Jorgenson, 31, of Arizona got her first dose of Moderna’s vaccine in mid-January, and second dose mid-February and developed blurred vision along with symptoms of headaches, “brain fog” and fatigue. She’s undergone CT and MRI scans and doctors don’t know what’s causing her problems,” she said.

“It’s frightening, stressful, and uncertain. I’m 31, and I have never in my life had double vision before,” she says.

Jorgenson said illness is affecting her ability to both work and drive. “I’m not currently driving at all, as it is just not safe.”

She has cut her at-home work schedule from 40 hours per week to about 25 hours per week, “but that’s also a struggle, because of the double vision, headache, brain fog, and fatigue.”

“I don’t know what the doctors can do from here,” she said.

Bleeding and clotting disorders

Numerous vision problems are associated with hemorrhaging and blood clotting incidents:

  • A 25-year-old from Massachusetts began experiencing symptoms on the day of receiving her first dose of Moderna’s vaccine in January and an MRI revealed “inflammation, and brain bleed and swelling,” according to the VAERS reportfiled by a healthcare professional.
  • An 83 year-old from Indiana who had Moderna’s vaccine and went blind in her left eye the same day. “Went to emergency room at Hospital Was told I have Blood clot in my eye causing the blindness and Ophthamologist says it will probably be permanent,” her report states.
  • A 50-year-old woman from Oklahoma with no prior health conditions experienced a central retinal vein occlusion (CRVO) 2 and ½ hours after receiving a second dose of Pfizer’s COVID-19 vaccine resulted in loss of sight to her right eye, according to another VAERS report. “I am currently prescribed baby aspirin and will have to get injections in my eye when macular edema occurs, an expected occurrence with a blood clot in the retinal vein.”
  • “Within 12 hours of receiving the 2nd dose of the Moderna vaccine, I experienced an occipital cerebral infarction in the left occipital lobe,” states the VAERS report of a 73-year-old Florida man. “As a result, I have a loss of peripheral vision in the right upper quadrant.”
  • Another VAERS report describes a 68-year-old California man’s four-day hospitalization and numerous interventions after his first dose of Pfizer’s vaccine: “Permanent loss of vision in right eye three weeks after receiving first COVID 19 vaccination. Diagnosed with Branch Retina Artery Occlusion (BRAO) clotting of the retinal artery.”

Previous coronavirus

Pennsylvania immunologist Hooman Noorchashm has warned about the potential for vaccinating the 20% to 30% of people who have already had a recent or underlying COVID infection may lead to catastrophic events. That may be the reason why a 52-year-old man from Michigan who was diagnosed with COVID-19 on December 13, 2020 who then received a series of shots on December 22 and January 10, 2021 was diagnosed one day after his second shot with opthalmic artery thrombus causing vision loss in his left eye.

Allergic eye disorders

Some eye disorders happened in the context of severe allergic or “anaphylactic” or “anaphylactoid” events for which there are 915 VAERS report. More than 60 reports refer to “anaphylaxis” and eye symptoms in the same event, as in the case of a 55-year-old asthmatic woman with food allergies who had a reaction to Pfizer’s second dose of COVID vaccine and according a VAERS report was put “under the care of an eye doctor for her severe double vision, eye crossing, and eye drooping.”

Shingles

Some eye pain reports are in association with herpes – or shingles — infection, which has already been raised as a potential elevated risk factor following COVID vaccination. According to a report on one 30-year-old woman, her “severe right side eye pain” and “vesicular rash with severe pain above right eyelid” developed after she got her Johnson & Johnson one-shot in January. She was diagnosed with Zoster Ophthalmicus of Right Eye and treated in urgent care. After her rash crusted she still had residual severe neuropathic pain at the time of the report nine days later.

Uveitis

In Great Britain, 35 reports of uveitis – an inflammation of the middle layer of the eye – following coronavirus vaccination were generated by April 21, about four months following the vaccines rollout in December.

This may seem a small number except that one 2016 study that looked for cases of “vaccine-associated” uveitis found 289 reports over 26 years of data from three databases – which works out to about 11 cases per year for all vaccinations. In which case, reports for uveitis are many fold higher than what one would expect to see from vaccination.

“The nature of Yellow Card reporting means that reported events are not always proven side effects,” according to the government website that catalogues the reports. “Some events may have happened anyway, regardless of vaccination.”

While public health officials have frequently stated that vaccine adverse events are only “one or two in a million” shots, the Medicines and Healthcare products Regulatory Agency (MHRA) for Britain states that for the Pfizer/BioNTech and AstraZeneca vaccines, the overall reporting rate is “around 3 to 6 Yellow Cards per 1,000 doses administered.”

As well, because both the U.S. VAERS the U.K. Yellow Card are passive collections systems, they tend to capture only a fraction of adverse events. A Harvard Pilgrim Healthcare study found that less than one percent of vaccine adverse events are reported to VAERS.

Asked about the high numbers of reported adverse eye events, a spokesperson for the MHRA, which oversees Yellow Card reports, said in an emailed statement: “We continually review Yellow Card data, as well as other data sources, to determine if reports may indicate any previously unrecognised risks.”

The statement added that the agency applies “statistical techniques” which compare events to what would be expected generally in the population.  

“Everything has to be looked at on a case by case basis, and there is no set trigger to determine whether something may be linked to a vaccine,” the MHRA statement said. “All reports are kept under review taking into account the information available and whether there are other plausible explanations.”

Among the 12,140 adverse events reported to Canada’s coronavirus vaccine adverse event reporting system by April 23, there is not a single account of an eye disorder— which, given the extraordinarily high numbers in other countries, raises questions about Canada’s reporting process.

COVID-Vaccinated Can ‘Shed’ Spike Protein, Harming Unvaccinated

America’s Frontline Doctors: COVID-vaccinated can ‘shed’ spike protein, harming unvaccinated

As these experimental vaccines create ‘spike proteins,’ vaccinated individuals ‘can shed some of these particles to close contacts’ causing disease in them, including in children.

By Patrick Delaney

 

LOS ANGELES, California, May 3, 2021 (LifeSiteNews) — In their latest issue brief, America’s Frontline Doctors (AFLDS) warned how spike proteins resulting from experimental COVID-19 gene therapy vaccines have the capacity to 1.) pass through the “blood-brain barrier” causing neurological damage, 2.) be “shed” by the vaccinated, bringing about sickness in unvaccinated children and adults, and 3.) cause irregular vaginal bleeding in women.

Released last week and titled “Identifying Post-vaccination Complications & Their Causes: an Analysis of Covid-19 Patient Data,” the stated purpose of the document is “to provide additional information for concerned citizens, health experts, and policymakers about adverse events and other post-vaccination issues resulting from the three experimental COVID-19 vaccines currently administered under EUA (emergency use authorization)” by the U.S. Food and Drug Administration (FDA).

The non-profit organization highlighted the thousands of adverse events which are related to these “vaccines” and captured by the Centers for Disease Control and Prevention’s (CDC) Vaccine Adverse Event Reporting System (VAERS). “Yet these complications have received a fraction of the attention paid to J&J’s blood-clotting controversy,” they lamented with dismay, asking, “Why?”

In taking a closer look at this data, AFLDS presents “some major categories of concern as-yet publicly unaddressed by either the FDA or CDC,” asserting that failure of these regulators “to consider these and other ‘known unknowns’ is a dereliction of basic medical research.”

They breakout their general categories of concern as shown below:

First, there are significant fears regarding the wide distribution of these new vaccines, which employ a new technology and remain only experimental without full approval from the FDA. Instead of employing an attenuated antigen response – as happens with conventional vaccines – these experimental agents introduce something called a “spike protein” into one’s system.

“It takes years to be sure something new is safe,” the AFLDS document confirms. “No one knows definitively the long-term health implications for the body and brain, especially among the young, related to this spike protein. In addition, if documented problems with the protein do arise, there will never be any way to reverse the adverse effects in those already vaccinated.”

Second, unlike conventional vaccines, these spike proteins, along with “lipid nanoparticles” have the capacity to pass through the “blood-brain barrier” which provides special protection for these sensitive areas of the body.

“There simply has not been enough time to know what brain problems and how often a brain problem will develop from that,” the document warns.

Risks from such penetration include “chronic inflammation and thrombosis (clotting) in the neurological system, contributing to tremors, chronic lethargy, stroke, Bell’s Palsy and ALS-type symptoms. The lipid nanoparticles can potentially fuse with brain cells, resulting in delayed neuro-degenerative disease. And the mRNA-induced spike protein can bind to brain tissue 10 to 20 times stronger than the spike proteins that are (naturally) part of the original virus.”

Third, as these experimental vaccines produce many trillions of spike proteins in their recipients, these vaccinated individuals “can shed some of these (spike protein) particles to close contacts,” causing disease in them.

In an email correspondence with LifeSiteNews, Dr. Simone Gold, the founder of AFLDS, directed this writer to an April 29 tweet where she posted a document from Pfizer’s experimental trials in which the pharmaceutical giant “acknowledges this mechanism” of potential shedding, she wrote. 

As the document states, one can be “exposed to [the] study intervention due to environmental exposure,” including “by inhalation or skin contact” with someone involved in the study, or with another who has been exposed in the same way.

And this, according to AFLDS, can be dangerous. As the issues brief continues, “the spike proteins are pathogenic (‘disease causing’) just like the full virus.” Furthermore, these “spike proteins bind more tightly than the fully intact virus” and thus cases around the world of “pericarditis, shingles, pneumonia, blood clots in the extremities and brain, Bell’s Palsy, vaginal bleeding and miscarriages have been reported in persons who are near persons who have been vaccinated.” Such shedding also “appears to be causing wide variety of autoimmune disease (where the body attacks its own tissue) in some persons.”

In addition, other more serious dangers to even the unvaccinated are possible due to the fact that these “spike proteins can cross the blood brain barrier, unlike traditional vaccines.”

Fourth, such shedding leaves children vulnerable if they are in proximity to parents and teachers who have received these experimental vaccines. While the threat of COVID-19 to the young is rightly described as “irrelevant,” including a 99.997% survival rate for those under 20 years of age, AFLDS is concerned some children may become symptomatic due to such proximity to the vaccinated. At such point there is a danger that “public health bureaucrats” might use such cases to “speculate that a child’s illness is related to a SARS-CoV-2 ‘variant,’” when it is a result of contact with vaccinated adults.

“Our other concern is that children could develop long-term chronic autoimmune disease including neurological problems due to the fact that children have decades ahead of them and trillions of the spike proteins mentioned above.”

Fifth, “AFLDS is aware of thousands of reports involving vaginal bleeding, post-menopausal vaginal bleeding, and miscarriages following COVID-19 vaccination as well as anecdotal reports of similar adverse events among those in close contact with the vaccinated.” While at this point the independent physicians organization “cannot comment definitively on the close contacts” other than to mention they “have heard reports of this worldwide,” the many reported incidents of post-vaccination vaginal bleeding establishes a clear “connection between the vaccine and irregular bleeding.”

“Despite this clear-cut evidence, menstrual-cycle changes were not listed among the FDA’s common side effects in its phase-three clinical participants. Women’s reproductive health needs to be taken seriously rather than waved away by agenda-driven public health officials,” the brief reads.

Finally, acknowledging the “irrepressible economic incentive among pharmaceutical companies” to market unnecessary and dangerous childhood COVID vaccinesboosters, and the like, AFLDS insists “Public health experts should stop and assess data on possible vaccine side effects and related post-vaccination questions before it is too late.”